Status:

COMPLETED

Novel Use of Extrapleural Autologous Blood Injection in CT-guided Percutaneous Lung Biopsy

Lead Sponsor:

Namik Kemal University

Conditions:

Lung Biopsy

Eligibility:

All Genders

Phase:

NA

Brief Summary

The purpose of this study is to evaluate the rate of iatrogenic pneumothorax and the need for intervention with extrapleural autologous blood injection (EPABI) along with intraparenchymal autologous b...

Detailed Description

The mechanism of pneumothorax is postulated to be due to the air leakage through the puncture hole when the needle is removed after the biopsy. However, pneumothorax may occur during the needle insert...

Eligibility Criteria

Inclusion

  • ≥18 years of age
  • Referred for CT guided biopsy of lung lesion
  • Target lesion of any size
  • Target lesion located any away from visceral pleura based on the needle path
  • Needle path without transgression of a pleural fissure, bleb, or bulla is possible
  • Coaxial biopsy technique using Bard 19-Gauge introducer needle
  • Needle length =16

Exclusion

  • Passage through non-aerated lung or tissue
  • More than 1 biopsy on the same side requiring more than 1 pleural puncture
  • History of prior ipsilateral lung interventions including:
  • Chest tube placement Surgery Pleurodesis Radiation treatment

Key Trial Info

Start Date :

October 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 31 2019

Estimated Enrollment :

139 Patients enrolled

Trial Details

Trial ID

NCT04415255

Start Date

October 1 2018

End Date

October 31 2019

Last Update

June 9 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tekirdag Namik Kemal University Medical Faculty Radiology Department

Tekirdağ, Turkey (Türkiye), 59100

Novel Use of Extrapleural Autologous Blood Injection in CT-guided Percutaneous Lung Biopsy | DecenTrialz